Vice President and Chief Medical Officer/ International Association of Providers of AIDS Care

Infectious Disease

Benjamin Young works in the field of Infectious Disease. He researched medicine at University of Colorado Denver School of Medicine. University of Colorado Denver School of Medicine is a top medical college. University of Colorado Denver School of Medicine is ranked 35/8 in Research/PrimaryCare. He received awards:"Clinical Academic Publication Award", "Peak Performers Award for Excellence in Infectious Diseases", "Hero", "Outstanding HIV/AIDS Clinician", "TheBody.com HIV Leadership Award", "Denvers Top Doctors", "Graduation with Honors", "Fellow - Medical Scientist Training Program", "University Fellow", "President's Undergraduate Fellow", "Departmental Honors and Distinction", "Alpha Omega Alpha" and "Top MD". Benjamin Young is a published physician as well. He has 19 publications published. The latest was: Controlling the HIV Epidemic With Antiretrovirals: Moving From Consensus to Implementation. Benjamin Young accepts Medicare.

Publications

---

• Controlling the HIV Epidemic With Antiretrovirals: Moving From Consensus to Implementation.
• Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006.
• Retention in Care within 1 Year of Initial HIV Care Visit in a Multisite US Cohort: Who's in and Who's Out?
• The HIV care cascade through time.
• Provider Guidance for Linking Patients to Antiretroviral Therapy Adherence Interventions: Recommendations from an IAPAC Advisory Committee on Adherence Monitoring and ...
• Achieving improvements across the HIV treatment cascade: a clinical management algorithm based on IAPAC's entry into and retention in care and antiretroviral therapy a...
• Inflammatory Biomarker Changes and Their Correlation with Framingham Cardiovascular Risk and Lipid Changes in Antiretroviral-Naive HIV-Infected Patients Treated for 14...
• ARIES 144 Week Results: Durable Virologic Suppression in HIV-Infected Patients Simplified to Unboosted Atazanavir/Abacavir/Lamivudine.
• Trends in Decline of Antiretroviral Resistance among ARV-Experienced Patients in the HIV Outpatient Study: 1999-2008.
• Immune reconstitution inflammatory syndrome: incidence and implications for mortality.
• Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, r...
• Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial.
• Transmission of integrase strand-transfer inhibitor multidrug-resistant HIV-1: case report and response to raltegravir-containing antiretroviral therapy.
• Adherence to antiretroviral therapy in an urban, free-care HIV clinic in Guatemala City, Guatemala.
• Similar virologic and immunologic efficacy with fosamprenavir boosted with 100 mg or 200 mg of ritonavir in HIV-infected patients: results of the LESS trial.
• A pilot study of abacavir/lamivudine and raltegravir in antiretroviral-naive HIV-1-infected patients: 48-week results of the SHIELD trial.
• Similar efficacy and tolerability of atazanavir compared with atazanavir/ritonavir, each with abacavir/lamivudine after initial suppression with abacavir/lamivudine pl...
• Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjects.

Schools

---

• University Of Colorado School Of Medicine

• University Of Colorado

• University of California At San Diego

Conditions Treated

---

• AIDS
• HIV (Human Immunodeficiency Virus)

Doctors Specialties

---

• Infectious Disease Medicine
• Infectious Disease

Accepted Insurances

---

Awards

---

• Clinical Academic Publication Award
• Peak Performers Award for Excellence in Infectious Diseases
• Hero
• Outstanding HIV/AIDS Clinician
• TheBody.com HIV Leadership Award
• Denver’s Top Doctors
• Graduation with Honors
• Fellow - Medical Scientist Training Program
• University Fellow
• President's Undergraduate Fellow
• Departmental Honors and Distinction
• Alpha Omega Alpha
• Top MD

Education

---

• University of Colorado
• University of Colorado Denver School of Medicine

Drug Facts

---

NPI NUMBER		1720062714
NPPES Provider LastName		YOUNG
NPPES Provider FirstName		BENJAMIN
NPPES Provider ZIPCode		802203901
NPPES Provider State		CO
Specialty Description		Infectious Disease
Total Claim Count		790.0
Distinct Opioid Count		5.0
Opioid Claim Count		82.0
Percent Opioid Claims		10.38

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1720062714
Last Name Of The Provider	YOUNG
First Name Of The Provider	BENJAMIN
View All

Similar Doctors

---

	Dr. Larry S. Fisher, MD This Doctor is OpenDoctor Recommended.
	Dr. Kenneth F. Baum, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert W. Belknap, MD This Doctor is OpenDoctor Recommended.
	Dr. Shannon H. Kasperbauer, MD This Doctor is OpenDoctor Recommended.
	Dr. William J. Burman, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Margaret P. McLees, MD This Doctor is OpenDoctor Recommended.
	Dr. Leland Shapiro, MD This Doctor is OpenDoctor Recommended.
	Dr. John H. Hammer, MD This Doctor is OpenDoctor Recommended.
	Dr. Matthew G. Terra, MD This Doctor is OpenDoctor Recommended.
	Dr. Kathryn L. Springer, MD This Doctor is OpenDoctor Recommended.
	Dr. Clay C. Watson, MD This Doctor is OpenDoctor Recommended.
	Dr. Miguel Mogyoros, MD This Doctor is OpenDoctor Recommended.
	Dr. Tsun Sheng N. Ku, MD This Doctor is OpenDoctor Recommended.
	Dr. Gwen A. Huitt, MD This Doctor is OpenDoctor Recommended.
	Dr. Vivian A. Cox, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog